RVL Pharmaceuticals plc Lessee, Operating Lease, Liability, to be Paid
RVL Pharmaceuticals plc had Lessee, Operating Lease, Liability, to be Paid of $538.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2023-03-20
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $538.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $1.48M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid $2.20M; Lessee, Operating Lease, Liability, to be Paid as first filed $3.10M.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid $5.60M.
| Period end | Lessee, Operating Lease, Liability, to be Paid | Lessee, Operating Lease, Liability, to be Paid as first filed |
|---|---|---|
| 2022-12-31 | $538.00K 10-K · filed 2023-03-20 | |
| 2021-12-31 | $1.48M 10-K · filed 2022-03-30 | |
| 2020-12-31 | $2.20M 8-K · filed 2021-09-08 | $3.10M 10-K · filed 2021-03-30 |
| 2019-12-31 | $5.60M 10-K · filed 2020-03-19 | |
| 2019-09-30 | $6.25M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $7.17M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $7.18M 10-Q · filed 2019-05-09 |